Evolent Health, Inc.
Simbol: EVH
NYSE
31.93
USDTržna cena danes
-27.2314
Razmerje P/E
0.0238
Razmerje PEG
3.69B
Kapaciteta MRK
- 0.00%
Donos DIV
Evolent Health, Inc. (EVH) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 677.41 | 192.8 | 188.2 | 266.3 | ||||||||||||
balance-sheet.row.short-term-investments | 118.9 | 13.8 | 14.5 | 75.7 | ||||||||||||
balance-sheet.row.net-receivables | 1480.17 | 446.7 | 254.7 | 130.6 | ||||||||||||
balance-sheet.row.inventory | -816.51 | 0 | -415.9 | -308.2 | ||||||||||||
balance-sheet.row.other-current-assets | 1020.3 | 30.3 | 451.1 | 435.3 | ||||||||||||
balance-sheet.row.total-current-assets | 2375.14 | 683.7 | 478.1 | 524 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 431.5 | 90.2 | 136.9 | 131.6 | ||||||||||||
balance-sheet.row.goodwill | 4469.59 | 1116.5 | 722.8 | 426.3 | ||||||||||||
balance-sheet.row.intangible-assets | 3157.46 | 752 | 442.8 | 279.8 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 7627.04 | 1868.6 | 1165.6 | 706.1 | ||||||||||||
balance-sheet.row.long-term-investments | 18.13 | 4.9 | 4.5 | 5.5 | ||||||||||||
balance-sheet.row.tax-assets | 25.53 | 12.1 | 0 | 39.4 | ||||||||||||
balance-sheet.row.other-non-current-assets | 108.87 | 20.9 | 32.3 | 13 | ||||||||||||
balance-sheet.row.total-non-current-assets | 8211.07 | 1996.6 | 1339.2 | 895.5 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 10586.21 | 2680.3 | 1817.3 | 1419.5 | ||||||||||||
balance-sheet.row.account-payables | 227.99 | 48.2 | 57.2 | 96.1 | ||||||||||||
balance-sheet.row.short-term-debt | 34.52 | 9.7 | 7.1 | 7.1 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.long-term-debt-total | 2596.52 | 635.1 | 469 | 273.4 | ||||||||||||
Deferred Revenue Non Current | 763.39 | 583.7 | 2.5 | 4.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 330.46 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 1593.18 | 610.3 | 363.4 | 330.4 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 3982.56 | 938.4 | 524.4 | 280.3 | ||||||||||||
balance-sheet.row.other-liabilities | 343.45 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 222.04 | 47.7 | 63.1 | 64.8 | ||||||||||||
balance-sheet.row.total-liab | 6207.46 | 1612.6 | 957.9 | 725.8 | ||||||||||||
balance-sheet.row.preferred-stock | 1695.41 | 178.4 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 345.76 | 1.2 | 1 | 0.9 | ||||||||||||
balance-sheet.row.retained-earnings | -2691.57 | -719.2 | -606.2 | -626.8 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -4.76 | -1.3 | -1.2 | -0.4 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 5033.92 | 1608.6 | 1465.7 | 1319.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 4378.76 | 1067.7 | 859.4 | 693.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 10586.21 | 2680.3 | 1817.3 | 1419.5 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-equity | 4378.76 | 1067.7 | 859.4 | 693.6 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 10586.21 | - | - | - | ||||||||||||
Total Investments | 119.15 | 4.9 | 19 | 5.5 | ||||||||||||
balance-sheet.row.total-debt | 2626.43 | 644.8 | 476.1 | 280.5 | ||||||||||||
balance-sheet.row.net-debt | 1949.02 | 452 | 287.9 | 14.2 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -113.04 | -113 | -19.2 | -37.6 | |||||||||||
cash-flows.row.depreciation-and-amortization | 125.7 | 123.4 | 67.2 | 60 | |||||||||||
cash-flows.row.deferred-income-tax | -97.46 | -31.3 | 0.3 | -0.5 | |||||||||||
cash-flows.row.stock-based-compensation | 40.5 | 40.5 | 34 | 16.7 | |||||||||||
cash-flows.row.change-in-working-capital | 67.77 | 21.9 | -104.4 | -13.6 | |||||||||||
cash-flows.row.account-receivables | -164.69 | -164.7 | -103 | -5.8 | |||||||||||
cash-flows.row.inventory | 0 | -10.7 | 0 | -14.1 | |||||||||||
cash-flows.row.account-payables | -6.72 | -6.7 | 13.2 | 7.3 | |||||||||||
cash-flows.row.other-working-capital | 232.94 | 204.1 | -14.6 | -1 | |||||||||||
cash-flows.row.other-non-cash-items | 119.11 | 101.1 | 10.5 | 13.8 | |||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 142.58 | 0 | 0 | 0 | |||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -28.75 | -28.7 | -38.4 | -25 | |||||||||||
cash-flows.row.acquisitions-net | -388.25 | 0.9 | 5.6 | -34.8 | |||||||||||
cash-flows.row.purchases-of-investments | 387.45 | -0.9 | -5.6 | -3 | |||||||||||
cash-flows.row.sales-maturities-of-investments | 0.87 | 0.9 | 5.6 | 0.5 | |||||||||||
cash-flows.row.other-investing-activites | -387.74 | -387.7 | -226.3 | 46.5 | |||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -415.54 | -415.5 | -259.1 | -15.8 | |||||||||||
cash-flows.row.debt-repayment | -464.47 | -464.2 | -219.7 | -98.8 | |||||||||||
cash-flows.row.common-stock-issued | 7.6 | 479.5 | 4.5 | 13.3 | |||||||||||
cash-flows.row.common-stock-repurchased | -15.29 | -15.3 | -18.3 | -3.9 | |||||||||||
cash-flows.row.dividends-paid | -18.79 | -18.8 | -14.9 | -1.3 | |||||||||||
cash-flows.row.other-financing-activites | 772.29 | 300.1 | 380 | 61.2 | |||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 281.34 | 281.3 | 131.5 | -29.5 | |||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -0.08 | -0.1 | -0.7 | -0.1 | |||||||||||
cash-flows.row.net-change-in-cash | 8.3 | 8.3 | -139.8 | -6.6 | |||||||||||
cash-flows.row.cash-at-end-of-period | 847.52 | 223.5 | 215.2 | 354.9 | |||||||||||
cash-flows.row.cash-at-beginning-of-period | 839.23 | 215.2 | 354.9 | 361.6 | |||||||||||
cash-flows.row.operating-cash-flow | 142.58 | 142.6 | -11.6 | 38.7 | |||||||||||
cash-flows.row.capital-expenditure | -28.75 | -28.7 | -38.4 | -25 | |||||||||||
cash-flows.row.free-cash-flow | 113.84 | 113.8 | -49.9 | 13.8 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1963.9 | 1963.9 | 1352 | 908 | ||||||||||||
income-statement-row.row.cost-of-revenue | 1503.43 | 1503.4 | 1035.4 | 657.6 | ||||||||||||
income-statement-row.row.gross-profit | 460.47 | 460.5 | 316.6 | 250.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 26.7 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 360.23 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 34955.47 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 33.15 | -62.5 | 67.2 | 60 | ||||||||||||
income-statement-row.row.operating-expenses | 481.52 | 481.5 | 336.5 | 279.5 | ||||||||||||
income-statement-row.row.cost-and-expenses | 1984.95 | 1985 | 1371.9 | 937.1 | ||||||||||||
income-statement-row.row.interest-income | 5.26 | 5.3 | 1.4 | 0.4 | ||||||||||||
income-statement-row.row.interest-expense | 54.2 | 54.2 | 15.6 | 25.4 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 34955.47 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | -144.24 | -132.4 | -2.2 | -60 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 33.15 | -62.5 | 67.2 | 60 | ||||||||||||
income-statement-row.row.total-operating-expenses | -144.24 | -132.4 | -2.2 | -60 | ||||||||||||
income-statement-row.row.interest-expense | 54.2 | 54.2 | 15.6 | 25.4 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 58.49 | 123.4 | 67.2 | 60 | ||||||||||||
income-statement-row.row.ebitda-caps | 46.38 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | -62.64 | -71.2 | -59.8 | 30.2 | ||||||||||||
income-statement-row.row.income-before-tax | -202.41 | -202.4 | -62.1 | -29.8 | ||||||||||||
income-statement-row.row.income-tax-expense | -89.36 | -89.4 | -43.4 | 0.5 | ||||||||||||
income-statement-row.row.net-income | -113.04 | -113 | -18.7 | -30.3 |
Pogosto zastavljeno vprašanje
Kaj je Evolent Health, Inc. (EVH) skupna sredstva?
Evolent Health, Inc. (EVH) skupna sredstva so 2680308000.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so 1067070000.000.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.234.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 1.002.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.058.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so -0.032.
Kaj je Evolent Health, Inc. (EVH) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je -113040000.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 644796000.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 481525000.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 192825000.000.